Dendritic cell reprogramming by endogenously produced lactic acid

Journal of Immunology

Volumn 191, Issue 6, 2013, Pages 3090-3099

  Nasi, Aikaterini ^a   Fekete, Tünde ^b   Krishnamurthy, Akilan ^c   Snowden, Stuart ^a   Rajnavölgyi, Eva ^b   Catrina, Anca I ^c   Wheelock, Craig E ^a   Vivar, Nancy ^c   Rethi, Bence ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 4; LACTIC ACID; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TUMOR NECROSIS FACTOR;

ARTICLE; AUTOCRINE EFFECT; CELL ACTIVATION; CELL CULTURE; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; OSTEOCLAST; PRIORITY JOURNAL; TH1 CELL;

AUTOCRINE COMMUNICATION; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; LACTIC ACID; POLYMERASE CHAIN REACTION; TRANSCRIPTOME;

EID: 84884225414     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300772     Document Type: Article

References (32)

1. Copier, J., M. Bodman-Smith, and A. Dalgleish. 2011. Current status and future applications of cellular therapies for cancer. Immunotherapy 3: 507-516.
2. Apetoh, L., C. Locher, F. Ghiringhelli, G. Kroemer, and L. Zitvogel. 2011. Harnessing dendritic cells in cancer. Semin. Immunol. 23: 42-49.
3. Palucka, K., and J. Banchereau. 2012. Cancer immunotherapy via dendritic cells. Nat. Rev. Cancer 12: 265-277.
4. Schuler, G. 2010. Dendritic cells in cancer immunotherapy. Eur. J. Immunol. 40: 2123-2130.
5. Verdijk, P., E. H. Aarntzen, C. J. Punt, I. J. de Vries, and C. G. Figdor. 2008. Maximizing dendritic cell migration in cancer immunotherapy. Expert Opin. Biol. Ther. 8: 865-874.
6. Morse, M. A., R. E. Coleman, G. Akabani, N. Niehaus, D. Coleman, and H. K. Lyerly. 1999. Migration of human dendritic cells after injection in patients with metastatic malignancies. Cancer Res. 59: 56-58.
7. Verdijk, P., E. H. Aarntzen, W. J. Lesterhuis, A. C. Boullart, E. Kok, M. M. van Rossum, S. Strijk, F. Eijckeler, J. J. Bonenkamp, J. F. Jacobs, et al. 2009. Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients. Clin. Cancer Res. 15: 2531-2540.
8. Cheng, P., C. A. Corzo, N. Luetteke, B. Yu, S. Nagaraj, M. M. Bui, M. Ortiz, W. Nacken, C. Sorg, T. Vogl, et al. 2008. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J. Exp. Med. 205: 2235-2249.
9. Gottfried, E., L. A. Kunz-Schughart, S. Ebner, W. Mueller-Klieser, S. Hoves, R. Andreesen, A. Mackensen, and M. Kreutz. 2006. Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. Blood 107: 2013-2021.
10. Rodriguez, P. C., C. P. Hernandez, D. Quiceno, S. M. Dubinett, J. Zabaleta, J. B. Ochoa, J. Gilbert, and A. C. Ochoa. 2005. Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma. J. Exp. Med. 202: 931-939.
11. Zea, A. H., P. C. Rodriguez, M. B. Atkins, C. Hernandez, S. Signoretti, J. Zabaleta, D. McDermott, D. Quiceno, A. Youmans, A. O'Neill, et al. 2005. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res. 65: 3044-3048.
12. Gogolak, P., B. Rethi, I. Szatmari, A. Lanyi, B. Dezso, L. Nagy, and E. Rajnavolgyi. 2007. Differentiation of CD1a- and CD1a+ monocyte-derived dendritic cells is biased by lipid environment and PPARg. Blood 109: 643-652.
13. Klechevsky, E., R. Morita, M. Liu, Y. Cao, S. Coquery, L. Thompson-Snipes, F. Briere, D. Chaussabel, G. Zurawski, A. K. Palucka, et al. 2008. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 29: 497-510.
14. Conti, L., M. Cardone, B. Varano, P. Puddu, F. Belardelli, and S. Gessani. 2008. Role of the cytokine environment and cytokine receptor expression on the generation of functionally distinct dendritic cells from human monocytes. Eur. J. Immunol. 38: 750-762.
15. Smed-Sörensen, A., M. Moll, T. Y. Cheng, K. Loré, A. C. Norlin, L. Perbeck, D. B. Moody, A. L. Spetz, and J. K. Sandberg. 2008. IgG regulates the CD1 expression profile and lipid antigen-presenting function in human dendritic cells via FcgRIIa. Blood 111: 5037-5046.
16. Lundstrom, S. L., R. Saluja, M. Adner, J. Z. Haeggstrom, G. P. Nilsson, and C. E. Wheelock. 2013. Lipid mediator metabolic profiling demonstrates differences in eicosanoid patterns in two phenotypically distinct mast cell populations. J. Lipid Res. 54: 116-126.
17. Acosta-Rodriguez, E. V., G. Napolitani, A. Lanzavecchia, and F. Sallusto. 2007. Interleukins 1b and 6 but not transforming growth factor-b are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8: 942-949.
18. Vander Heiden, M. G., L. C. Cantley, and C. B. Thompson. 2009. Understanding theWarburg effect: the metabolic requirements of cell proliferation. Science 324: 1029-1033.
19. Everts, B., E. Amiel, G. J. van der Windt, T. C. Freitas, R. Chott, K. E. Yarasheski, E. L. Pearce, and E. J. Pearce. 2012. Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells. Blood 120: 1422-1431.
20. Halestrap, A. P., and N. T. Price. 1999. The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem. J. 343: 281-299.
21. Appel, S., V. Mirakaj, A. Bringmann, M. M. Weck, F. Grünebach, and P. Brossart. 2005. PPAR-g agonists inhibit Toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kB pathways. Blood 106: 3888-3894.
22. Coutant, F., S. Agaugué, L. Perrin-Cocon, P. André, and V. Lotteau. 2004. Sensing environmental lipids by dendritic cell modulates its function. J. Immunol. 172: 54-60.
23. Faveeuw, C., S. Fougeray, V. Angeli, J. Fontaine, G. Chinetti, P. Gosset, P. Delerive, C. Maliszewski, M. Capron, B. Staels, et al. 2000. Peroxisome proliferator-activated receptor g activators inhibit interleukin-12 production in murine dendritic cells. FEBS Lett. 486: 261-266.
24. Szatmari, I., P. Gogolak, J. S. Im, B. Dezso, E. Rajnavolgyi, and L. Nagy. 2004. Activation of PPARg specifies a dendritic cell subtype capable of enhanced induction of iNKT cell expansion. Immunity 21: 95-106.
25. Szatmari, I., A. Pap, R. Rü hl, J. X. Ma, P. A. Illarionov, G. S. Besra, E. Rajnavolgyi, B. Dezso, and L. Nagy. 2006. PPARg controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells. J. Exp. Med. 203: 2351-2362.
26. Szatmari, I., D. Töröcsik, M. Agostini, T. Nagy, M. Gurnell, E. Barta, K. Chatterjee, and L. Nagy. 2007. PPARg regulates the function of human dendritic cells primarily by altering lipid metabolism. Blood 110: 3271-3280.
27. Yang, X. Y., L. H. Wang, K. Mihalic, W. Xiao, T. Chen, P. Li, L. M. Wahl, and W. L. Farrar. 2002. Interleukin (IL)-4 indirectly suppresses IL-2 production by human T lymphocytes via peroxisome proliferator-activated receptor g activated by macrophage-derived 12/15-lipoxygenase ligands. J. Biol. Chem. 277: 3973-3978.
28. Rivollier, A., M. Mazzorana, J. Tebib, M. Piperno, T. Aitsiselmi, C. Rabourdin-Combe, P. Jurdic, and C. Servet-Delprat. 2004. Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment. Blood 104: 4029-4037.
29. Walenta, S., andW. F. Mueller-Klieser. 2004. Lactate: mirror and motor of tumor malignancy. Semin. Radiat. Oncol. 14: 267-274.
30. Laborde, E. A., S. Vanzulli, M. Beigier-Bompadre, M. A. Isturiz, R. A. Ruggiero, M. G. Fourcade, A. C. Catalan Pellet, S. Sozzani, and M. Vulcano. 2007. Immune complexes inhibit differentiation, maturation, and function of human monocytederived dendritic cells. J. Immunol. 179: 673-681.
31. Del Prete, A., P. Zaccagnino, M. Di Paola, M. Saltarella, C. Oliveros Celis, B. Nico, G. Santoro, and M. Lorusso. 2008. Role of mitochondria and reactive oxygen species in dendritic cell differentiation and functions. Free Radic. Biol. Med. 44: 1443-1451.
32. Krawczyk, C. M., T. Holowka, J. Sun, J. Blagih, E. Amiel, R. J. DeBerardinis, J. R. Cross, E. Jung, C. B. Thompson, R. G. Jones, and E. J. Pearce. 2010. Tolllike receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 115: 4742-4749.